Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Magnolia Regenerative Medicine vs Mint Med

Magnolia Regenerative Medicine
Site position #205

Lower grade

Mint Med
Site position #45

Higher grade

The verdict

Mint Med takes it — 78.7/100 to 66.7/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMint Med +23
67
90
Dose & formulationMint Med +16
64
80
Clinical oversightMagnolia Regenerative Medicine +12
67
55
Labs & monitoringMint Med +19
64
83
FulfillmentMint Med +9
73
82
Contract termsMint Med +19
67
86
Magnolia Regenerative Medicine · top barMint Med · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMagnolia Regenerative MedicineMint Med
WeighScore66.7/10078.7/100
GradeCC+
Site position#205#45
Semaglutide$119/mo (billed monthly; the advertised $99 is a three-month prepay)$117/mo
Tirzepatide$199/mo (billed monthly; the advertised $179 is a three-month prepay)$159/mo
Coverage26 states (including Washington, D.C.)36 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Magnolia Regenerative Medicine

Site position #205 · C

Strengths

  • Publishes an exact state list — 26 states including Washington, D.C. — rather than a nationwide claim it then hedges
  • Prices both a month-to-month plan and a three-month prepay for each molecule, and states the totals rather than only a per-month equivalent
  • Prices its lab panels openly at $89 and $189 and says plainly that lab costs are not included
  • A large priced peptide and hormone catalog sits beside the GLP-1 lines

Where it loses points

  • The advertised “starting at $99” and “starting at $179” are three-month prepay figures, not monthly rates
  • A first-time patient cannot reach the advertised price at all: answering that this is a first course produces titration plans at $119 and $199 a month
  • A third pair of figures for differently named products — semaglutide with B-6 from $109 and tirzepatide with B-6 from $159 — appears on one page and nowhere else
  • The Terms' only cancellation channel is an email address at a domain with no mail records, and three FAQ pages route questions to the same address
  • All 127 URLs in the site's own sitemap point at a domain that does not resolve
  • The Terms describe a pharmacy transfer fee as “one hundred five dollars ($125.00)”, contradicting themselves inside a single clause
  • A strict no-refund policy applies, and a $50 non-refundable fee attaches to a missed appointment
  • No pharmacy, compounding class, clinician or NPI is named anywhere on the site
Mint Med

Site position #45 · C+

FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard